ONCOSIL MEDICAL LTD (ASX:OSL) Announces Security Consolidation
Security Consolidation Details
ONCOSIL MEDICAL LTD has announced a security consolidation where every 400 pre-consolidation securities will be consolidated into one post-consolidation security.
Timetable
The consolidation is effective from 30 May 2025. The last day for trading pre-consolidation securities is 2 June 2025. Trading in post-consolidation securities will commence on 3 June 2025 on a deferred settlement basis, reverting to normal T+2 settlement on 13 June 2025. The record date for the consolidation is 4 June 2025, and the issue date is 12 June 2025.
Impact on Securities
Post-consolidation, the number of ORDINARY FULLY PAID securities will reduce from 4,606,580,162 to 11,516,450. Various options and performance rights will also be consolidated, with adjusted exercise prices reflecting the consolidation ratio.
Motley Fool contributor Kiarra Jackson has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.
